Keywords: اینترلوکین; AHAB; Adult Health and Behavior; BDI-II; Beck Depression Inventory-II; BMI; body mass index; CES-D; Center for Epidemiological Studies; CFA; confirmatory factor analysis; CFI; comparative fit index; CI; confidence interval; CRP; C-reactive protein; CVD; c
مقالات ISI اینترلوکین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین; α-SMA; α smooth muscle actin; CGRP; calcitonin gene related peptide; CTGF; connective tissue growth factor; DETCs; dendritic epidermal T cells; ECM; extracellular matrix; EGF; epidermal growth factor; eNOS; endothelial nitric oxide synthase; EPCs; endot
Keywords: اینترلوکین; APO; Apolipoprotein; BMI; body mass index; CTR; control; CVD; cardiovascular disease; DHA; Docosahexaenoic acid; DBP; diastolic blood pressure; EPA; Eicosapentaenoic acid; FA; Fatty acids; IL; Interleukin; IMT; Intima-media thickness; IR; Insulin resistan
Keywords: اینترلوکین; BME; Basal Medium Eagle; CCL2; C-C motif chemokine ligand 2; CM; conditioned medium; cSCC; cutaneous squamous cell carcinoma; CTGF; connective tissue growth factor; CXCL1; C-X-C motif chemokine ligand 1; DMEM; Dulbecco's modified Eagle's medium; EGF;
Keywords: اینترلوکین; AANAT; arylalkylamine N-acetyltransferase; AE2; Clâ/HCO3- anion exchanger 2; ANIT; α-naphthylisothiocyanate; BA; biliary atresia; BDL; bile duct ligation; cAMP; adenosine 3â²,5â²-cyclic monophosphate; CCA; cholangiocarcinoma; CCl4; carbon tetrachlo
Keywords: اینترلوکین; ALT; alanine aminotransferase; APAP; acetaminophen; AST; aspartate aminotransferase; ATP; adenosine triphosphate; BLC; B lymphocyte chemoattractant; CD30L; cluster of differentiation 30 ligand; CHFD; choline-deficient high-fat diet; Cyp2e1; cytochrome P45
Keywords: اینترلوکین; ADP; adenosine diphosphate; Apo; apolipoprotein; AT III; antithrombin III; AUC; area under the curve; BMI; body mass index; CET; cholesterol ester transfer; CRP; C-reactive protein; CVD; cardiovascular disease; FMD; flow mediated dilation; FVII; factor VI
Keywords: اینترلوکین; 3-CQA; 3-caffeoylquinic acid; 3,4-diCQA; 3,4-dicaffeoylquinic acid; 3,5-diCQA; 3,5-dicaffeoylquinic acid; 4,5-diCQA; 4,5-dicaffeoylquinic acid; 5-CQA; 5-caffeoylquinic acid; AAPH; 2,2â²-azobis(2-amidinopropane) dihydrochloride; ABTS; 2,2-azino-bis(3-ethy
Keywords: اینترلوکین; C difficile; Toxins; Cysteine Protease; Autoprocessing; Inflammation; ACPD; CPD domain of TcdA; aTcdA; GTD deficient TcdA; Bgt; GTD of TcdB; Br; RBD of TcdB; CPD; cysteine protease domain; CDI; Clostridium difficile infection; GT; glucosyltransferase; GTD
Keywords: اینترلوکین; Akt; protein kinase B; Alg; alginate; ALP; alkaline phosphatase; ATF; activating transcription factor; BFR; bone formation rate; BMD; bone mineral density; BMP; bone morphogenetic protein; BSP; bone sialoprotein; BTE; bone tissue engineering; CIA; collage
Keywords: اینترلوکین; 3-MP; 3-mercaptopyruvate; 3-MST; 3-mercaptopyruvate sulfurtransferase; AAT; aspartate amino transferase; AE1; anion exchanger-1; AGEs; advanced glycation end products; AKI; acute kidney injury; AMPK; AMP-activated protein kinase; AT1; angiotensin receptor
Keywords: اینترلوکین; Microglia; Stress; Alzheimer's disease; Neurodegeneration; Neuroinflammation; Synaptic remodeling; Microglial phenotypes; Dark microglia; Aβ; Amyloid beta; ABCA7; ATP-binding cassette transporter A7; AD; Alzheimer's disease; APOE; Apolipoprotein E; APP;
Keywords: اینترلوکین; AAC; abdominal aortic constriction; ADAMS; a disintegrin and metalloproteases; ADAMTS; a distingetrin and metalloproteinase with a thrombospondin domain; Ang II; angiotensin II; BM; basement membrane; BMP-1; bone morphogenic protein-1; CITP; carboxy-termi
Keywords: اینترلوکین; COX; cyclooxygenase; DAPI; 4,6-diamidino-2-phenylindole; EDTA; ethylene diamine tetraacetic acid; IκBα; nuclear factor kappa light polypeptide gene enhancer in B cells inhibitor; LPS; lipopolysaccharide; MnPO; median preoptic nucleus; mPGES; microsomal
Keywords: اینترلوکین; 5-HT; serotonin; ABLE; Age of Blood Evaluation; ADP; adenosine diphosphate; ATP; adenosine triphosphate; BC; buffy coat; BTHC; n-butyryl tri-n-hexyl citrate; CCI; corrected count increment; CD; cluster of differentiation; CD40L; CD40 ligand; CD62P; P-sele
Keywords: اینترلوکین; AHR; aryl hydrocarbon receptor; BBB; blood-brain barrier; CNS; central nervous system; CIS; clinically isolated syndrome; EDSS; expanded disability status scale; EAE; experimental autoimmune encephalomyelitis; DC; dendritic cell; DMF; dimethyl fumarate; D
Keywords: اینترلوکین; Ac; acetyl; AD-mix; asymmetric dihydroxylation mix; ATP; adenosine triphosphate; Bn; benzyl; Boc; tert-butyloxycarbonyl; Bu; butyl (n-Bu, n-butyl; I; isobutyl; sec-Bu; sec-butyl; t-Bu; tert-butyl); Bz; benzoyl; CAL-B; Candida antartcia lipase-B; CAN; ceri
Keywords: اینترلوکین; AGO; Argonaute; ARG1; arginase1; ATM; adipose tissue macrophage; BAT; brown adipose tissue; BMDM; bone marrow derived macrophage; C/EBP; CCAAT-enhancer-binding proteins; CCL2; C-C Motif Chemokine Ligand 2; CCR2; C-C Motif Chemokine Receptor 2; CLS; crown-
Keywords: اینترلوکین; ACEi; angiotensin-converting-enzyme inhibitor; ACR; albumin-to-creatinine ratio; AHI; apnea-hypopnea index; AKI; acute kidney injury; ARB; angiotensin II receptor blocker; BAT; brown adipose tissue; BMI; body mass index; BP; blood pressure; BSA; body surf
Keywords: اینترلوکین; diacerein; epidermolysis bullosa; keratin; rare genodermatosis; AE; adverse event; BSA; body surface area; CI; confidence interval; EBS; epidermolysis bullosa simplex; EBS-gen/sev; generalized severe epidermolysis bullosa simplex; IFN; intermediate filame
Keywords: اینترلوکین; ECM; Extracellular matrix; TIMP-1; tissue inhibitor of matrix metalloproteinases-1; HA; hyaluronic acid; IPF; idiopathic pulmonary fibrosis; FDA; Food and Drug Administration; bFGF; basic fibroblast growth factor; IFN-γ; interferon-γ; IL; interleukin; P
Keywords: اینترلوکین; Aspirin-exacerbated respiratory disease (AERD); Asthma; Aspirin (acetylsalicylic acid, ASA); Chronic rhinosinusitis with nasal polyps; Nonsteroidal antiinflammatory drugs (NSAID); Hypersensitivity; Intolerance; AERD; aspirin-exacerbated respiratory diseas
Keywords: اینترلوکین; Brain injury; Spinal cord injury; Innate and adaptive immunity; Inflammatory response; Immunotherapy; Secondary injury; APC; antigen-presenting cells; ASC; apoptosis-associated speck-like protein containing a carboxy-terminal CARD; BBB; blood-brain barrie
Keywords: اینترلوکین; JAK/STAT; IL-22; hBD3; αCAG; cholesteryl-6'-O-aycl-α-glucoside; αCPG; cholesteryl-6'-O-phosphatidyl-α-glucoside; ALI; air-liquid interface; CagA; cytotoxin-associated gene A; hBD3; human β-defensin 3; IFN; interferon; IFNG; interferon gamma; IL;
Keywords: اینترلوکین; Aβ; amyloid-β peptide; AD; Alzheimer's disease; APP; amyloid precursor protein; ATP; adenosine triphosphate; BBB; blood-brain barrier; CNS; central nervous system; ECM; extracellular matrix; Hsp; heat shock protein; IFN; interferon; IκB; NF-κB inhib
Keywords: اینترلوکین; 3-MT; 3-methoxytyramine; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; serotonin (5-hydroxytryptamine); 5-HTP; 5-hydroxy-L-tryptophan; Am; amygdala; Ap; arcopallium; Arch; archistriatum; ATD; acute tryptophan depletion; BBB; blood-brain-barrier; CL; control l
Keywords: اینترلوکین; DNA variant; genetics; genome-wide association; inflammasome; inflammation; inflammatory bowel disease; innate immunity; interleukin; missing heritability; mutation; NOD-like receptor (NLR); nucleotide oligomerization domain (NOD) protein; periodontal dis
Keywords: اینترلوکین; Cardiovascular diseases; inflammation; prenatal inflammatory exposure; maternal immune activation; developmental reprogramming; NF-κB; ACE; Angiotensin-converting enzyme; ACTH; Adrenocorticotropic hormone; Ang II; Angiotensin II; ApoE; Apolipoprotein E;
Keywords: اینترلوکین; ADAM; A Disintegrin And Metalloproteinase; ADAMTS; a disintegrin and metalloproteinase with thrombospondin motifs; Akt; RAC-alpha serine/threonine-protein kinase; AP1; transcription factor AP-1; BMP; bone morphogenetic protein; DNMT; DNA methyl-transferas
Keywords: اینترلوکین; ADAMs; a disintegrin and metalloproteinases; ADAMTS; ADAMs with thrombospondin motifs; Col; collagen; CS; chondroitin sulfate; CTGF; connective tissue growth factor; DS; dermatan sulfate; ECM; extracellular matrix; EGF; epidermal growth factor; EMT; epith
Keywords: اینترلوکین; HA; hyaluronic acid; Tregs; regulatory T cells; T1DM; type 1 diabetes mellitus; IBD; inflammatory bowel disease; RA; rheumatoid arthritis; MHC; major histocompatibility complex; HLA; human leukocytes antigens; TLRs; toll-loke receptors; PRRs; pattern reco
Keywords: اینترلوکین; PASI; Psoriasis Area and Severity Index; IL; interleukin; fzd; frizzled receptors; IFN; interferon; ADAM; a disintegrin and metalloproteinase; EGF; epidermal growth factor; TGF; transforming growth factor; TPA; 12-o-tetradecanoyl phorbol-13-acetate; VEGF;
Keywords: اینترلوکین; AI; anaemia of inflammation; ARE; anti-oxidant responsive element; ATP; adenosine triphosphate; Bmp; bone morphogenetic protein; CD; cluster of differentiation; C/EBP; CCAAT enhancer-binding protein; CO; carbon monoxide; CREB; cyclic adenosine monophospha
Keywords: اینترلوکین; AAV; adeno-associated viruses; AMS; activated macrophage suspension; Ang; angiopoietin; APC; activated protein C; antimiRs; miRNA antisense oligonucleotides; bFGF; basic FGF; BM; bone marrow; cDNA; complementary DNA; CLI; critical limb ischemia; CRISPR-Ca
Keywords: اینترلوکین; BD; blood derivatives; EGF; endothelial growth factor; ECM; extracellular matrix; FG; fibrin glue; FGF; fibroblast growth factor; GFs; growth factors; HGF; hepatocyte growth factor; hASCs; human adipose-derived stem cells; HA; hyaluronic acid; IGF; insuli
Keywords: اینترلوکین; Vegetable oils; Beneficial effects; Repeatedly heated oils; Adverse effect; CVD; ABTS-2; 2â²-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); ACE; angiotensin converting enzymes; ALA; alpha linolenic acid; ALP; alkaline phosphatase; ALT; alanine trans
Keywords: اینترلوکین; Atherosclerosis; Cardiovascular diseases; Cell cycle; Proliferation; Pulmonary hypertension; Restenosis; Signaling pathway; Vascular smooth muscle cells; ACE; angiotensin converting enzyme; aFGF; acidic FGF; Ang II; angiotensin II; AP-1; activating protei
Keywords: اینترلوکین; ALK1; activin receptor-like kinase1; ANG/Ang; angiopoietin; Bcl-xL; b-cell lymphoma-extra large; BM; bone marrow; BMDCs; bone marrow derived cells; BMP; bone morphogenetic protein; Bv8; bombina variagata peptide 8; CAFs; cancer/carcinoma associated fibrob
Keywords: اینترلوکین; ADMSC; Adipose tissue derived mesenchymal stem cells; bFGF; Basic fibroblast growth factor; Bgn; Biglycan; BM; Bone marrow; BMMSC; Bone marrow derived mesenchymal stem cells; BMP; Bone morphogenetic protein; Col; Collagen; COMP; Cartilage oligomeric matri
Keywords: اینترلوکین; ABC; ATP-binding cassette; AJ; adherens junction; Ang; angiopoietin; ApoE; apolipoprotein E; AQP4; aquaporin 4; BBB; blood-brain barrier; cAMP; cyclic AMP; CSF; cerebrospinal fluid; EAAT; excitatory amino acid transporter; EC; endothelial cell; ECF; extra
Keywords: اینترلوکین; Ginger; Multiple sclerosis; Experimental autoimmune encephalomyelitis; Therapeutic potentials; AP-1; Activator protein 1; APCs; Antigen-presenting cells; ASC; apoptosis speck-like protein containing CARD; BAFF; B cell-activating factor belonging to the TN
Keywords: اینترلوکین; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; α-SMA; alpha- smooth muscle actin; BBB; blood-brain barrier; BDNF; brain derived neurotrophic factor; bFGF or FGF2; basic fibroblast growth factor; BrdU; bromodeoxyuridine; CIMT; const
Keywords: اینترلوکین; AT; atrial thrombus; HCM; hypertrophic cardiomyopathy; IL; interleukin; MMP; matrix metalloproteinase; TIMP; tissue inhibitor of matrix metalloproteinase; TGF; transforming growth factor; TNF; tumor necrosis factor; Thrombus; Cardiac remodeling; Adipokine
Keywords: اینترلوکین; BMI; body mass index; CTX; C-terminal telopeptide of type I collagen; IL; interleukin; LCH; Langerhans cell histiocytosis; PINP; procollagen type I N-terminal propeptide; PTH; parathyroid hormone; Langerhans cell histiocytosis (LCH); Disease activity; P1N
Keywords: اینترلوکین; ASC; apoptosis-associated speck-like protein containing a caspase activation and recruitment domain; DAMPs; damage-associated molecular patterns; IL; interleukin; LPC; lysophosphatidylcholine; LPS; lipopolysaccharide; NLRC4; nucleotide-binding domain and
Keywords: اینترلوکین; guttate psoriasis; HLA-C*06:02; psoriasis; ustekinumab; BSA; body surface area; HLA; human leukocyte antigen; IL; interleukin; PGA; physician global assessment; Th; T helper;
Keywords: اینترلوکین; AHI; apnoea hypopnea index; BMI; body mass index; IL; interleukin; LMI; leg movement index; LOS; length of stay; LTRA; leukotriene antagonist; OSA; obstructive sleep apnoea; OAHI; obstructive apnoea-hypopnea index; OR; odds ratio; NREM; non-rapid eye mo
Keywords: اینترلوکین; Janus kinase inhibitor; Myelofibrosis; Pulmonary cryptococcosis; Pulmonary nodules; Ruxolitinib; CT; computed tomography; IL; interleukin; JAK; Janus kinase; TNF; tumor necrosis factor;
Keywords: اینترلوکین; ASCs; adipose stromal cells; ATMs; adipose tissue macrophages; CD; cluster of differentiation; Ptgs2; Prostaglandin-Endoperoxide Synthase 2; DAG; des-acyl ghrelin; FCS; fetal calf serum; GHSR1a; growth hormone secretagogue receptor; IL; interleukin; MCP-1
Keywords: اینترلوکین; AGEs; Advanced glycation end products; ADMA; Asymmetric dimethylarginine; cAMP; Cyclic adenosine monophosphate; DPP-4; Dipeptidyl peptidase 4; GLP-1; Glucagon-like peptide 1; GLP-1R; Glucagon-like peptide 1 receptor; HMGB-1; High mobility group box 1 prot